Theratechnologies to be bought by CB Biotechnology for $254M

4 days ago 1
Wooden blocks with text M and A on light blue paper, business concept. MA - short for mergers and acquisitions

Shares of Theratechnologies (NASDAQ:THTX) rose after the company announced on Thursday that it will be acquired by CB Biotechnology, a subsidiary of Future Pak, in a deal valued at $254M.

CB Biotechnology plans to purchase Theratechnologies for $3.01 per share in

Recommended For You

More Trending News

Read Entire Article